Replies to post #423174 on Amarin Corp Plc (AMRN)

[JRoon71]

Zip, you are right. And I am hoping that they release the new formulation in order to differentiate it from "just fish oil".

One of the things that is often overlooked or glossed over is the difference between EPA nd DHA. Many of the medical journals that look at the effects of "Omega 3's" on various health markers often only give a cursory nod to the impact of EPA vs. DHA. Many will conclude that "Omega 3's" don't help with certain health markers, by pointing to VITAL and STRENGTH in their analysis.

This is where I think the prior, prior management team got it wrong. They incorrectly assumed that they could just let the drug stand on its own, without making a strong argument about what Vascepa is (and what it is NOT). And I believe that the company never really recovered from that marketing blunder (among other, notable things).